CTOs on the Move

Medicine in Motion

www.medmotion.org

 
Medicine in Motion (MM) is a 501(c)(3) nonprofit organization composed of a diverse group of healthcare providers whose mission is to address medical burnout through fitness, interdisciplinary community building, and philanthropy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Mid South Health System

Mid South Health System is a Jonesboro, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Urgent Cares of America

Urgent Cares of America is a Clayton, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Groups360

Groups360™️ was founded in 2014 with the goal of simplifying and transforming the ways meetings are booked. The company`s search engine, GroupSync™️, using its proprietary matching algorithms designed specifically for meeting planners, has helped place thousands of events at the right venue, saving planners time and money. GroupSync`s price predictor tool delivers improved transparency, reducing time and effort required to book meetings for both the hotel and the planner. Groups360`s management team has decades of experience in the meetings and events industry and provides the right mix of technology and experienced advisors. Using GroupSync, planners can search more than 200,000 properties in 225 countries and territories.

HealthWorks

HealthWorks is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.